Mitochondrial electron transport chain enzyme (Complex I (CI), Complex II (CII), Complex III (CIII), Complex IV (CIV))

The mitochondrial electron transport chain consists of four major multi-subunit enzyme complexes embedded in the inner mitochondrial membrane. These complexes (I-IV) facilitate electron transfer from reduced electron carriers (NADH, FADH₂) to oxygen, the final electron acceptor, creating a proton gradient that drives ATP synthesis via ATP synthase (complex V). In addition to their core bioenergetic function, ETC enzymes are primary sources of cellular ROS, play roles in signaling, apoptosis, and are implicated in numerous disease processes when dysfunctional. Pharmacological targeting of ETC enzymes spans inhibition (anticancer, anti-parasitic drugs), antioxidant therapies, and mitochondrial metabolism modulators[1][2][4][5][7][12]. Note: For structured data or therapeutic action, specifying the exact ETC enzyme (Complex I, II, III, or IV) is necessary. The current target name, "Mitochondrial electron transport chain enzyme," is not sufficiently precise[1][7][5].

Other names

Electron transport chain complexesComplex I/II/III/IVrespiratory chain enzymesoxidative phosphorylation enzymesETC enzyme

Inhibition of electron flow (block electron transfer causing cell death) Enhancement or bypass of electron flow (improve mitochondrial function, delay aging[4]) Induction of ROS (pro-apoptotic/cytotoxic effect in cancer therapy[2][12]) Protection against oxidative stress (antioxidants, UCP activation[4][5])